SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (139)7/7/1999 6:34:00 AM
From: LLCF  Read Replies (1) | Respond to of 395
 
<Unis said the researchers hope to have test results in six months to a year. If they look promising, more extensive, long-term studies will follow, he said.">

Interesting how cold hard cash get things done... the rest of the "DAN" protocol [diet and nystatin] is being totally ignored because there's little money involved.

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News